{"nctId":"NCT02492841","briefTitle":"Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth","startDateStruct":{"date":"2014-04"},"conditions":["Caries","Dental Pulp Exposure"],"count":169,"armGroups":[{"label":"Mineral trioxide aggregate (MTA)","type":"EXPERIMENTAL","interventionNames":["Drug: Mineral trioxide aggregate"]},{"label":"Calcium hydroxide","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Calcium hydroxide"]},{"label":"Biodentine","type":"EXPERIMENTAL","interventionNames":["Drug: Biodentine"]}],"interventions":[{"name":"Mineral trioxide aggregate","otherNames":["MTA Pro Root"]},{"name":"Calcium hydroxide","otherNames":["Calcium hydroxide Hertz"]},{"name":"Biodentine","otherNames":["Active biosilicate. Septodont."]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Systemically healthy patients\n* Patients with at least one full or partial tooth root development\n* Clinical examination of the tooth must be selected diagnostic tests that are consistent with reversible pulpitis\n* Radiographic examination should show images of normal tissues without signs of internal resorption, the remaining healthy coronary should be sufficient for an indication of direct restoration\n* Teeth that have pulp exposure not exceeding 1 mm in size.\n\nExclusion Criteria:\n\n* Every child with systemic and / or neurological conditions that make it impossible to focus on conventional dental clinic\n* Teeth uncontrolled excessive bleeding during communication pulp those aiming or have plans to move during that time period of 8 months .","healthyVolunteers":true,"sex":"ALL","minimumAge":"7 Years","maximumAge":"16 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Parameters Evaluated After Treatment","description":"vitality test with electric device cold and hot test radiographic evaluation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"19","spread":null},{"groupId":"OG002","value":"25","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Adverse Effects","description":"Name any adverse effects caused by treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":[]}}}